1 / 12

Action Plan for Acrylamide Food Advisory Committee Meeting

Action Plan for Acrylamide Food Advisory Committee Meeting. Terry C. Troxell, Ph.D. Lauren M. Posnick, Sc.D. FDA February 24-25, 2002. Today’s Talk. Development and content of the Action Plan. FDA’s Overall Goal. Ongoing work on the Action Plan. History. Swedish report, April 24, 2002

albany
Download Presentation

Action Plan for Acrylamide Food Advisory Committee Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Action Plan for AcrylamideFood Advisory Committee Meeting Terry C. Troxell, Ph.D. Lauren M. Posnick, Sc.D. FDA February 24-25, 2002

  2. Today’s Talk • Development and content of the Action Plan. • FDA’s Overall Goal. • Ongoing work on the Action Plan.

  3. History • Swedish report, April 24, 2002 • CFSAN method, June 20, 2002 • WHO/FAO consultation, June 25-27, 2002 • Interagency roundtable, Sept. 24, 2002 • CFSAN public meeting, Sept. 30, 2002

  4. History II • JIFSAN/NCFST Workshop, Oct. 28-30 • Subcommittee on Contaminants and Natural Toxicants, Dec. 4-5, 2002. • FDA presented the Draft Action Plan for comment at the public meeting and the Subcommittee meeting.

  5. Action Plan • The Action Plan outlines FDA’s goals and planned activities on acrylamide in food over the next several years. • The Plan discusses FDA’s intentions to work with other federal agencies and participate in international efforts.

  6. Action Plan II • The Draft plan included sections on Testing Foods, Toxicology, Formation, Methodologies, Meetings and Collaborative Projects, Consumer Messages and Regulatory Options.

  7. Considerations in Developing the Action Plan • Scientific review at FDA and WHO indicated cause for concern • Acrylamide is a known animal carcinogen and known human neurotoxicant at high doses. • Consumption in tens of micrograms range. • Scientific review also revealed significant gaps in knowledge of acrylamide in food.

  8. Considerations in Developing the Action Plan II • Intense worldwide interest in acrylamide in food. • Ideally, work of all parties would be coordinated. • Research indicates acrylamide is formed through traditional cooking practices.

  9. FDA’s Overall Goal Through scientific investigation and risk management decision making, prevent and/or reduce potential risk of acrylamide in foods to the greatest extent feasible.

  10. Ongoing Work • Plan revised in response to input by the Subcommittee. • Today, we are presenting the revised Plan to the Food Advisory Committee for assistance in finalizing the Plan.

  11. Ongoing Work II • Projects outlined in Plan. • CCFAC, March 17-21, 2003. • WHO/FAO JECFA, 2004 (tentative).

  12. Next Talks • Report on the Subcommittee meeting, including comments on the Action Plan. • Review the Revised Action Plan in detail.

More Related